Author details

Full Name

Tomas Olsson

Affiliation

ORCID

Career Start Year

1978

Papers

696

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37494984	Overlapping protein profile of first-episode psychosis patients and common handling markers may indicate presence of preanalytical variability: A response to "Immunological protein profiling of first-episode psychosis patients identifies CSF and blood bio		2023
37930324	Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.		2023
37903821	Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis.		2023
37802637	Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage.		2023
38077366	Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.		2023
37558400	Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.		2023
37400429	Publisher Correction: Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality.	Nat Commun	2023
37196088	Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.		2023
37192793	Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab.		2023
37006489	The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective survey.		2023
36629499	Association between exposure to combustion-related air pollution and multiple sclerosis risk.		2023
37188663	Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy.	Nat Commun	2023
37001984	Influence of oral tobacco versus smoking on multiple sclerosis disease activity and progression.		2023
36692896	Observed associations between indicators of socioeconomic status and risk of multiple sclerosis in Sweden are explained by a few lifestyle-related factors.		2023
36690431	Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study.		2023
37435869	The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.		2023
36863085	Myopia in late adolescence and subsequent multiple sclerosis among men.		2023
37366345	Inverse association between Mediterranean diet and risk of multiple sclerosis.		2023
37301908	Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality.	Nat Commun	2023
36608656	The genetic history of Scandinavia from the Roman Iron Age to the present.	Cell	2023
36539267	Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study.		2023
37106402	Prominent epigenetic and transcriptomic changes in CD4 and CD8 T cells during and after pregnancy in women with multiple sclerosis and controls.		2023
36789885	Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study.		2023
36603296	Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort.		2023
37522464	The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease-modifying therapies.		2023
35309300	Smoking Attributable Risk in Multiple Sclerosis.	Frontiers in Immunology	2022
36182700	The population genomic legacy of the second plague pandemic.	Curr Biol	2022
35967338	Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy.	Frontiers in Immunology	2022
35496759	Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden.	Multiple Sclerosis Journal - Experimental, Translational and Clinical	2022
35808856	B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients.	Eur J Neurol	2022
35560551	Copy number variations across the blood-brain barrier in multiple sclerosis.	Annals of Clinical and Translational Neurology	2022
35993445	COVID-19 clinical outcomes and DMT of MS patients and population-based controls.	Annals of Clinical and Translational Neurology	2022
35476434	Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.	Sci Adv	2022
35667837	Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results From Randomized Phase 2b Core and Extension Studies.	Neurology	2022
35607517	Risk of serious infections in multiple sclerosis patients by disease course and disability status: Results from a Swedish register-based study.	Brain, Behavior, and Immunity - Health	2022
35470158	Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset.	Ann Rheum Dis	2022
35470161	Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function.	Annals of the Rheumatic Diseases	2022
35978722	Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment.	BMJ Neurology Open	2022
36570871	Association between brain volume and disability over time in multiple sclerosis.		2022
34124961	High antibody levels against human herpesvirus-6A interact with lifestyle factors in multiple sclerosis development.	Multiple Sclerosis Journal	2022
34984719	Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse.	Annals of Neurology	2022
34597789	Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein Biomarkers.	Molecular and Cellular Proteomics	2021
32162580	Comorbid disease burden among MS patients 1968-2012: A Swedish register-based cohort study.	Multiple Sclerosis Journal	2021
31712720	Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression.	Mol Psychiatry	2021
31705424	Appropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decision.	Journal of Nuclear Cardiology	2021
34295471	Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.	Clin Transl Immunology	2021
34180956	Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.	JAMA Neurol	2021
34291599	Type O blood group associates with higher anti-JC polyomavirus antibody levels.	Brain and Behavior	2021
34239545	Alcohol Consumption and Risk of Common Autoimmune Inflammatory Diseases-Evidence From a Large-Scale Genetic Analysis Totaling 1 Million Individuals.	Frontiers in Genetics	2021
33693538	Hospital-diagnosed infections before age 20 and risk of a subsequent multiple sclerosis diagnosis.	Brain	2021